Favorable response to mammalian target of rapamycin... : Hepatology (original) (raw)
Clinical Observations in Hepatology
Favorable response to mammalian target of rapamycin inhibition in a young patient with unresectable fibrolamellar carcinoma of the liver
Bill, Ruben1; Montani, Matteo2; Blum, Benedikt3; Dufour, Jean‐François4; Escher, Robert1; Bühlmann, Michael*,1,5
1Department of Internal MedicineSpital EmmentalBurgdorfSwitzerland
2Institute of PathologyUniversity of BernBernSwitzerland
3Department of RadiologySpital EmmentalBurgdorfSwitzerland
4Hepatology Unit, Department of Clinical ResearchUniversity Hospital BernBernSwitzerland
5Division of Medical OncologySpital EmmentalBurgdorfSwitzerland
* ADDRESS CORRESPONDENCE AND REPRINT REQUESTS:
Michael Bühlmann, M.D.
Division of Medical Oncology, Spital Emmental
Oberburgstrasse 54
3400 Burgdorf, Switzerland
E‐mail: [email protected]
Telephone: +41 34 421 23 36
© 2018 by the American Association for the Study of Liver Diseases.